March 2006
ACTION ITEMS
Under Public Scrutiny: A preliminary exploration of the public’s view of the National Pharmace
Pharmaceutical policy is central to the sustainability of not only national pharmacare programs, but the long-term stability of health care systems as a whole. But what do Canadians know and understand about the National Pharmaceutical Strategy and the government's plans. read more | comments
“It’s Curtains For You” - Continuing news from the Superbug World
A study from the Queen Elizabeth Hospital in Birmingham has highlighted a hitherto overlooked source of the killer super-bug MRSA read more | comments
MESSAGE FROM THE PRESIDENT
Communication involves writing smarter
Spring is more than tulips and daffodils, RRSPs and T4s. It's Annual Report time - working with designers and layout artists to produce a document that is appealing to the eye, compact and interesting to the read. It's also CAPA budget time. read more | comments
COMMENT AND PERSPECTIVE
Clinical Trials: What the patient participant needs to know
As patients we are never far from science in its various forms. It's natural then that we should pay close attention to the nightmarish scenario created in the UK by the Phase I clinical trial for a type of monoclonal antibody developed as a potential treatment for some autoimmune diseases. read more | comments
Fun in the sun: Summer camp for JIA kids
Swimming, sailing, canoeing, windsurfing, a rope course, crafts and a hot tub contributed to the camp experience for JIA kids in Alberta. read more | comments
Together we can ... promote patient-centered healthcare worldwide
Together we can ..." - the theme of the International Alliance of Patients' Organizations second Global Patients Congress focused on developing strategies to bring patients to the centre of healthcare systems. More comments
Inside the briefcase: Take a look
-
Inside the briefcase: Take a look
- Exercise and arthritis survey attempts to identify barriers to participation
- $2.5 million research grant targeted at management of Spondyloarthritis - Ankylosing Spondylitis and Psoriatic Arthritis
- Chronic pain and the interest in chronic pain is rising
TELLING IT LIKE IT IS
The short end of JIA: How biologics improved Trevor’s growth
Living with JIA can have many repercussions but with the advent of TNF inhibitors (biologics), stunted growth doesn't have to be one of them. Read Trevor's story. read more | comments
